451 related articles for article (PubMed ID: 37415827)
1. Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease.
Kayongo A; Nyiro B; Siddharthan T; Kirenga B; Checkley W; Lutaakome Joloba M; Ellner J; Salgame P
Front Cell Infect Microbiol; 2023; 13():1146571. PubMed ID: 37415827
[TBL] [Abstract][Full Text] [Related]
2. TB meets COPD: An emerging global co-morbidity in human lung disease.
O'Toole RF; Shukla SD; Walters EH
Tuberculosis (Edinb); 2015 Dec; 95(6):659-663. PubMed ID: 26386744
[TBL] [Abstract][Full Text] [Related]
3. Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.
Schwander S; Dheda K
Am J Respir Crit Care Med; 2011 Mar; 183(6):696-707. PubMed ID: 21075901
[TBL] [Abstract][Full Text] [Related]
4. Increased cytokines response in patients with tuberculosis complicated with chronic obstructive pulmonary disease.
Tang S; Cui H; Yao L; Hao X; Shen Y; Fan L; Sun H; Zhang Z; Huang JA
PLoS One; 2013; 8(4):e62385. PubMed ID: 23626814
[TBL] [Abstract][Full Text] [Related]
5. Impact of Previous Pulmonary Tuberculosis on Chronic Obstructive Pulmonary Disease: Baseline Results from a Prospective Cohort Study.
Wang Y; Li Z; Li F
Comb Chem High Throughput Screen; 2023; 26(1):93-102. PubMed ID: 35388750
[TBL] [Abstract][Full Text] [Related]
6. Airflow obstruction and chronic obstructive pulmonary disease are common in pulmonary tuberculosis even without sequelae findings on chest X-ray.
Park HJ; Byun MK; Lee J; Kim CY; Shin S; Kim Y; Rhee CK; Jung KS; Yoo KH
Infect Dis (Lond); 2023 Aug; 55(8):533-542. PubMed ID: 37243367
[TBL] [Abstract][Full Text] [Related]
7. History of pulmonary tuberculosis affects the severity and clinical outcomes of COPD.
Park HJ; Byun MK; Kim HJ; Ahn CM; Kim DK; Kim YI; Oh JY; Yoon HK; Yoo KH; Jung KS
Respirology; 2018 Jan; 23(1):100-106. PubMed ID: 28845558
[TBL] [Abstract][Full Text] [Related]
8. Post-tuberculosis lung disease and chronic obstructive pulmonary disease.
Gai X; Allwood B; Sun Y
Chin Med J (Engl); 2023 Aug; 136(16):1923-1928. PubMed ID: 37455331
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease.
Jo YS; Park JH; Lee JK; Heo EY; Chung HS; Kim DK
Int J Chron Obstruct Pulmon Dis; 2017; 12():2433-2443. PubMed ID: 28860738
[TBL] [Abstract][Full Text] [Related]
10. Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.
Wu MF; Jian ZH; Huang JY; Jan CF; Nfor ON; Jhang KM; Ku WY; Ho CC; Lung CC; Pan HH; Wu MC; Liaw YP
BMC Cancer; 2016 Oct; 16(1):778. PubMed ID: 27724847
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of post primary tuberculosis: immunity and hypersensitivity in the development of cavities.
Hunter RL; Actor JK; Hwang SA; Karev V; Jagannath C
Ann Clin Lab Sci; 2014; 44(4):365-87. PubMed ID: 25361920
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis.
Hunter RL
Tuberculosis (Edinb); 2016 Mar; 97():8-17. PubMed ID: 26980490
[TBL] [Abstract][Full Text] [Related]
13. Comparison in Outcome of Patients with Post TB-Destroyed Lung and COPD Admitted with Respiratory Failure.
Thorve SM; Awad NT; Nair JP; Waghmare SR; Gp G; Nair GS
J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431271
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils in Tuberculosis-Associated Inflammation and Lung Pathology.
Muefong CN; Sutherland JS
Front Immunol; 2020; 11():962. PubMed ID: 32536917
[TBL] [Abstract][Full Text] [Related]
15. Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease.
Guiedem E; Pefura-Yone EW; Ikomey GM; Nkenfou CN; Mesembe M; Yivala MM; Chendi BH; Jacobs GB; Chegou NN; Okomo MCA
BMC Immunol; 2020 Oct; 21(1):52. PubMed ID: 32998687
[TBL] [Abstract][Full Text] [Related]
16. [Progress in management of severe tuberculosis or tuberculosis with severe complication].
Kimura H; Imaizumi K
Kekkaku; 2014 May; 89(5):571-82. PubMed ID: 24979949
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study.
Lee CH; Lee MC; Shu CC; Lim CS; Wang JY; Lee LN; Chao KM
BMC Infect Dis; 2013 Apr; 13():194. PubMed ID: 23631563
[TBL] [Abstract][Full Text] [Related]
18. Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study.
Kim CJ; Yoon HK; Park MJ; Yoo KH; Jung KS; Park JW; Lim SY; Shim JJ; Lee YC; Kim YS; Oh YM; Kim S; Yoo CG
Int J Chron Obstruct Pulmon Dis; 2017; 12():1589-1596. PubMed ID: 28615931
[TBL] [Abstract][Full Text] [Related]
19. New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.
Gupta N; Kumar R; Agrawal B
Front Immunol; 2018; 9():709. PubMed ID: 29692778
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis: a disease without boundaries.
Fogel N
Tuberculosis (Edinb); 2015 Sep; 95(5):527-31. PubMed ID: 26198113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
